Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Apr;204(4):327.e1-6.
doi: 10.1016/j.ajog.2011.02.024.

Maternal insulin resistance and preeclampsia

Collaborators, Affiliations
Randomized Controlled Trial

Maternal insulin resistance and preeclampsia

John C Hauth et al. Am J Obstet Gynecol. 2011 Apr.

Abstract

Objective: The purpose of this study was to determine whether mid-trimester insulin resistance is associated with subsequent preeclampsia.

Study design: This was a secondary analysis of 10,154 nulliparous women who received vitamin C and E or placebo daily from 9-16 weeks gestation until delivery. Of these, 1187 women had fasting plasma glucose and insulin tested between 22 and 26 weeks gestation. Insulin resistance was calculated by the homeostasis model assessment of insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index.

Results: Obese women were twice as likely to have a HOMA-IR result of ≥75th percentile. Hispanic and African American women had a higher percentage at ≥75th percentile for HOMA-IR than white women (42.2%, 27.2%, and 16.9%, respectively; P < .001). A HOMA-IR result of ≥75th percentile was higher among the 85 nulliparous women who subsequently had preeclampsia, compared with women who remained normotensive (40.5% vs 24.8%; adjusted odds ratio, 1.9; 95% confidence interval, 1.1-3.2). Quantitative insulin sensitivity check index results were similar to the HOMA-IR results.

Conclusion: Midtrimester maternal insulin resistance is associated with subsequent preeclampsia.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Enrollment, randomization, and follow-up of participants

Similar articles

Cited by

References

    1. Himsworth HP. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;227:127–30. - PubMed
    1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Obesity. Williams Obstetrics. 23rd. New York, NY: McGraw Hill; 2010. pp. 946–57.
    1. American College of Obstetricians and Gynecologists. Weight Control: Assessment and management. Clinical updates in women's health care. 2003;II(3)
    1. Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids late in normal pregnancy. Am J Obstet Gynecol. 1981;140:730–6. - PubMed
    1. Lind T, Bell S, Gilmore E, et al. Insulin disappearance rate in pregnant and non-pregnant women, and in non-pregnant women given GHRIH. Eur J Clin Invest. 1977;7:47. - PubMed

Publication types

Grants and funding